The main market opportunities in the eosinophilic esophagitis pipeline include focusing on novel therapeutic approaches, potential development of first-in-class treatments like IRL201104, targeting ...
The global eosinophilic esophagitis drug market size is expected to reach US$ 180.5 million by 2028 according to a new study by Report Ocean. The report “Eosinophilic Esophagitis Drug Market Report, ...
Aqilion, a Swedish biopharma company developing therapies for diseases driven by chronic inflammation and dysregulated immune ...
Positive Results from Clinical Pharmacokinetic Study for the Eosinophilic Esophagitis Specific Formulation with the Drug Candidate AQ280Aqilion today announces positive results from the ARIA-2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback